# Aliath Bioventures

> Aliath Bioventures is a VC fund backing Biotechnology and Life Science. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 2
- Last investment: Apr 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/aliathbio
- Website: https://www.aliathbio.com

Aliath Bioventures is a investment firm focuses on Health care sectors.

## Contacts

5 contacts available for Aliath Bioventures. Shizune tracks 1 team members at Aliath Bioventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/aliath-bioventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Life Science | 1 | 50% |
| Medical Device | 1 | 50% |
| Consumer Electronics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Montserrat Vendrell | Co-Founder & Partner | 1 | https://shizune.co/investors/profile/montserrat-vendrell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DeepUll | DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise. | $56.9M | Series C | Apr 29, 2025 |  |
| INBRAIN Neuroelectronics | INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $49.8M | Series B | Oct 29, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [Asabys Partners](https://shizune.co/investors/profile/asabys-partners) — VC Fund, 2 deals together
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 2 deals together
- [Avançsa](https://shizune.co/investors/profile/avancsa) — VC Fund, 1 deal together
- [AXIS Participaciones Empresariales](https://shizune.co/investors/profile/axisparticipacionesempresariales) — VC Fund, 1 deal together
- [Columbus Venture Partners](https://shizune.co/investors/profile/columbus-venture-partners) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/eic-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Aliath Bioventures invest in?

Aliath Bioventures invests primarily in Biotechnology, Life Science and Medical Device startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Aliath Bioventures?

Public channels for Aliath Bioventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Aliath Bioventures?

The team at Aliath Bioventures includes Montserrat Vendrell (Co-Founder & Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co